Compare BIO-TECHNE Corp (TECH) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Vanguard International High Dividend Yield ETF — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Vanguard International High Dividend Yield ETF trades at $102.9 (market cap $22.80B). The key difference: Vanguard International High Dividend Yield ETF is far larger — about 2× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Vanguard International High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Vanguard International High Dividend Yield ETF for 50 Days on average.
| TECH | VYMI | |
|---|---|---|
Market Cap | $11.37B | $22.80B |
Volume | 3,153,511 | 1,300,061 |
Sector | Health | Broad Market / Factor |
52-Week High | $72.61 | $107.13 |
52-Week Low | $43.31 | $82.92 |
Typical Hold Time | 63 Days | 50 Days |
Enterprise Value | $11.40B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
VYMI trades at $100.23, down 1.11% with a bearish technical signal from moving averages. The ETF offers international diversification with a focus on high dividend yields, recently announcing a $0.82 dividend payment scheduled for September 2026. Recent institutional buying activity from firms like Envestnet and Corient Private Wealth indicates growing institutional interest despite the current technical weakness.
The outlook remains constructive given VYMI's strong historical performance (14.13% 5-year average annual return) and dividend growth potential. Key risks include global market volatility and currency fluctuations affecting international holdings. The ETF's financials-heavy portfolio (43.6% allocation) positions it to benefit from rising global interest rates, though this concentration also increases sector-specific risk exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Vanguard International High Dividend Yield ETF
VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →
